Conavi Medical Corp.
CNVI.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 485.71% | 12.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 485.71% | 12.62% | |||
| Cost of Revenue | 3,328.57% | 101.16% | |||
| Gross Profit | 441.29% | -55.64% | |||
| SG&A Expenses | 27.69% | -12.54% | |||
| Depreciation & Amortization | -1.02% | 4.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.73% | -10.94% | |||
| Operating Income | -10.35% | 11.20% | |||
| Income Before Tax | -91.68% | -18.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -91.68% | -18.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -91.68% | -18.21% | |||
| EBIT | -10.35% | 11.20% | |||
| EBITDA | -10.64% | 11.51% | |||
| EPS Basic | -69.95% | 23.58% | |||
| Normalized Basic EPS | 5.11% | 47.31% | |||
| EPS Diluted | -69.95% | 23.58% | |||
| Normalized Diluted EPS | 5.11% | 47.31% | |||
| Average Basic Shares Outstanding | 12.63% | 54.88% | |||
| Average Diluted Shares Outstanding | 12.63% | 54.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||